The JA PCM kick-off meeting took place in Brussels on 14-15 January 2026, marking the official launch of the European Joint Action on Personalised Cancer Medicine (JA PCM)!
The Joint Action brings together 29 European countries and over 140 partner organisations to advance personalised cancer care across Europe. Coordinated by Sciensano (the Belgian public health institute), the project aims to build a sustainable cross-border network that promotes innovation, equity, and collaboration across all stages of personalised cancer care—from prevention and diagnosis to treatment, follow-up, and tertiary prevention.
Curious about the key points from the JA PCM kick-off meeting and our vision and mission for the next four years? Read the full press release below.
